Summary
Europe’s pharmaceutical industry is facing unprecedented challenges in the development of new medicines due to long development timelines, high failure rates and the increasing costs of testing new drug candidates. Solutions are urgently needed to streamline...
More information & hyperlinks
Web resources: | http://www.pearrl.eu |